Zymeworks (ZYME) Current Leases (2021 - 2026)
Zymeworks (ZYME) reported Current Leases of $3.3 million for Q1 2026, up 0.64% on a YoY basis from $3.3 million in Q1 2025, and down 5.53% sequentially from $3.5 million in Q4 2025.
Zymeworks (ZYME) Current Leases (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Current Leases data on file, last reported at $3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 0.64% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 0.64% YoY), and the FY2025 full-year result was $3.5 million, up 26.68% from the prior year.
- Current Leases retreated to $3.3 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $4.6 million in Q3 2022 to a low of $2.7 million in Q4 2024.
- A 5-year average of $3.5 million and a median of $3.4 million in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases jumped 153.59% in 2022 and tumbled 35.7% in 2024, its largest moves.
- Tracing ZYME's Current Leases over 5 years: stood at $3.3 million in 2022, then increased by 28.27% to $4.3 million in 2023, then sank by 35.7% to $2.7 million in 2024, then climbed by 26.68% to $3.5 million in 2025, then fell by 5.53% to $3.3 million in 2026.
- Business Quant data shows ZYME's Current Leases at $3.3 million in Q1 2026, $3.5 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | 3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.28 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Dec 31, 2021 | 1.31 Mn |